Hester Biosciences Limited

NSE:HESTERBIO.NS

2496.55 (INR) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006
Operating Activities:
Net Income 188.89401.54535.02501.03413.262568.561361.219307.854243.313169.837133.679144.065118.969111.838119.624110.4135.64286.338
Depreciation & Amortization 171.74206.95165.81133.14132.299117.55496.59370.01857.51359.17254.14844.27141.23444.77942.33438.43736.8464.409
Deferred Income Tax 000000000000000000
Stock Based Compensation 000000000000000000
Change In Working Capital 36.25-208.38-386.84-7.76-136.483-99.761-24.5451.053-82.78240.901-59.712-50.418-37.593-50.321-1.188-41.337-46.24336.46
Accounts Receivables 5.29-249.65-87.7982.47-256.3358.811-60.925-7.469-82.313-41.5139.798-14.407000000
Inventory 92.29-94.28-131.617.46-131.821-103.637-60.4082.091-45.12165.063-44.871-38.484-48.831-57.181-52.491-47.071-20.139-22.445
Accounts Payables -35.41119.64-100.6780.6398.636.1064.29316.26212.167000000000
Other Working Capital -25.9215.91-66.78-188.32153.038-61.04135.862-1.038-37.662-24.163-14.841-11.93311.2376.8651.3035.735-26.10458.905
Other Non Cash Items 84.46-164.15-225.91-45.88-26.157-104.252-53.024-30.948-23.608-31.705-33.678-22.5461923.963-24.436-29.794-27.715-9.61
Operating Cash Flow 481.34235.9688.08580.53382.92482.101380.242347.977194.435238.20594.438115.372141.611130.259136.33477.70698.53117.598
Investing Activities:
Investments In Property Plant And Equipment -243.97-777.62-957.1-407.42-734.981-226.531-229.707-302.433-138.975-200.028-147.863-253.504-107.176-38.577-35.388-34.7-91.939-288.263
Acquisitions Net 00.25-208.150.429.811.139-26.3471.4643.769-5.25-16.495-3.4790-250000
Purchases Of Investments 0-2.53-213.21-0.42-23.299-8.428-3.053-2.271-0.683-2.158-0.711-1.137000000
Sales Maturities Of Investments 02.28213.2110.74-9.81-1.13900.6831.7641.8050.340.655000000
Other Investing Activites -1.517.63-0.6312.9613.5492.6620.81-0.095-0.532-22.4318.86631.9195.031.3140.8110.9171.5492.632
Investing Cash Flow -245.48-769.99-1,165.88-383.72-744.731-232.297-258.298-301.845-138.426-228.062-145.863-225.546-102.145-62.263-34.577-33.784-90.39-285.63
Financing Activities:
Debt Repayment -299.99389.21,168.69-228.97181.25189.668-5.92288.00613.04686.51518.084161.515-50.163-10.235-85.71-28.706-60.22277.069
Common Stock Issued 003.9819.640007.30414.05248.8870049.3216.44000103.627
Common Stock Repurchased 00-8.03000000000000000
Dividends Paid -68.05-85.07-85.07-56.15-71.79-102.555-64.504-34.878-51.892-16.859-17.014-5.725-18.173-14.795-12.978-12.978-10.382-5.562
Other Financing Activities 107.59113.4532.4883.2977.97-60.599-40.3627.304-28-1.85772.747-56.81128.902-27.4760-2.2700
Financing Cash Flow -260.45417.581,116.1-182.19186.19226.515-110.78718.345-67.37421.78573.81898.98-18.394-68.48-98.688-43.954-70.604175.134
Other Information:
Effect Of Forex Changes On Cash 1.570.51-3.49-37.2418.426.8770.31800.001-0000000-00
Net Change In Cash -4.08-115.9434.81-22.62-175.619283.19711.47564.477-11.36331.92922.393-11.19421.072-0.4843.069-0.031-62.4647.101
Cash At End Of Period 127.48131.56247.5212.69230.853406.472123.275114.33949.86276.80145.31222.91936.9999.0879.5716.5026.5338.836